Activation of Ecto-5′-Nucleotidase in the Blood and Hearts of Patients With Chronic Heart Failure

Journal of Cardiac Failure

Volumn 14, Issue 5, 2008, Pages 426-430

  Fujita, Masashi ^a   Asakura, Masanori ^b   Sanada, Shoji ^c   Funaya, Hiroharu ^a   Tsukamoto, Osamu ^a   Komamura, Kazuo ^b   Asanuma, Hiroshi ^b   Taketani, Satoshi ^a   Isomura, Tadashi ^d   Nakamaru, Kenji ^e   Furukawa, Hidehiko ^e   Sawa, Yoshiki ^a   Hori, Masatsugu ^a   Kitakaze, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d Hayama Heart Center   (Japan)

^e DAIICHI SANKYO CO   (Japan)

Author keywords

Adenosine; ecto 5 nucleotidase; heart failure

Indexed keywords

ADENOSINE; ECTO 5' NUCLEOTIDASE;

ADULT; AORTA; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HEART; HEART FAILURE; HEART MUSCLE; HUMAN; HUMAN TISSUE; MALE; NEW YORK HEART ASSOCIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

5'-NUCLEOTIDASE; ADENOSINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; SEVERITY OF ILLNESS INDEX; STROKE VOLUME;

EID: 44349186897     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.01.011     Document Type: Article

References (20)

1. Hori M., and Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 18 (1991) 565-574
2. Berne R.M. The role of adenosine in the regulation of coronary blood flow. Circ Res 47 (1980) 807-813
3. Kitakaze M., Node K., Komamura K., Minamino T., Kosaka H., Kuzuya T., et al. Intracoronary administration of adenosine triphosphate increases coronary blood flow and attenuates the severity of myocardial ischemic injury in dogs. Cardiovasc Drugs Ther 13 (1999) 407-414
4. Minamino T., Kitakaze M., Asanuma H., Tomiyama Y., Shiraga M., Sato H., et al. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. J Clin Invest 101 (1998) 1643-1653
5. Funaya H., Kitakaze M., Node K., Minamino T., Komamura K., and Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 95 (1997) 1363-1365
6. Kitakaze M., Hori M., Morioka T., Minamino T., Takashima S., Okazaki Y., et al. Alpha 1-adrenoceptor activation increases ecto-5'-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 91 (1995) 2226-2234
7. Savic V., Stefanovic V., Ardaillou N., and Ardaillou R. Induction of ecto-5'-nucleotidase of rat cultured mesangial cells by interleukin-1 beta and tumour necrosis factor-alpha. Immunology 70 (1990) 321-326
8. Yamane R., Nakamura T., Matsuura E., Ishige H., and Fujimoto M. A simple and sensitive radioimmunoassay for adenosine. J Immunoassay 12 (1991) 501-519
9. Node K., Kitakaze M., Minamino T., Tada M., Inoue M., Hori M., et al. Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart. Br J Pharmacol 120 (1997) 273-281
10. Smith K., Varon H.H., Race G.J., Paulson D.L., Urschel H.C., and Mallams J.T. Serum 5'-nucleotidase in patients with tumor in the liver. Cancer 19 (1966) 1281-1285
11. Vatner D.E., Asai K., Iwase M., Ishikawa Y., Shannon R.P., Homcy C.J., et al. Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart. Am J Cardiol 83 (1999) 80H-85H
12. Mehra M.R., Uber P.A., and Potluri S. Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts. Am J Med Sci 324 (2002) 267-275
13. Aukrust P., Gullestad L., Ueland T., Damas J.K., and Yndestad A. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med 37 (2005) 74-85
14. Shen W., Asai K., Uechi M., Mathier M.A., Shannon R.P., Vatner S.F., et al. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100 (1999) 2113-2118
15. Zhang J., Wilke N., Wang Y., Zhang Y., Wang C., Eijgelshoven M.H., et al. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study. Circulation 94 (1996) 1089-1100
16. Parmely M.J., Zhou W.W., Edwards III C.K., Borcherding D.R., Silverstein R., and Morrison D.C. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 151 (1993) 389-396
17. Kalsi K.K., Yuen A.H., Rybakowska I.M., Johnson P.H., Slominska E., Birks E.J., et al. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation-a potential mechanism of protection in heart failure. Cardiovasc Res 59 (2003) 678-684
18. Kitakaze M., Minamino T., Node K., Koretsune Y., Komamura K., Funaya H., et al. Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure. Cardiovasc Drugs Ther 12 (1998) 307-309
19. Loh E., Rebbeck T.R., Mahoney P.D., DeNofrio D., Swain J.L., and Holmes E.W. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 99 (1999) 1422-1425
20. Asakura M., Asanuma H., Kim J., Liao Y., Nakamaru K., Fujita M., et al. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res 30 (2007) 781-787